Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,420.00
Bid: 2,415.00
Ask: 2,435.00
Change: -5.00 (-0.21%)
Spread: 20.00 (0.828%)
Open: 2,460.00
High: 2,460.00
Low: 2,420.00
Prev. Close: 2,425.00
MGNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorship Changes

12 Dec 2023 07:00

RNS Number : 3963W
Morgan Sindall Group PLC
12 December 2023
 

 

12 December 2023

 

 

Morgan Sindall Group plc

 

Directorship changes

 

Morgan Sindall Group plc (the 'Company') today announces that Steve Crummett, Finance Director, has informed the Board of his intention to retire from the Company on 31 December 2024.

 

The Board also announces that following a search process, Kelly Gangotra, currently Chief Financial Officer, Healthcare Sector at Halma plc and previously Chief Financial Officer of Skanska UK, has been selected to succeed Steve as Finance Director.

 

Kelly will be appointed as Finance Director and become a member of the Board on a date to be agreed, expected to be around the third quarter of 2024, when Steve will step down from both roles. This will then allow for a period of transition until Steve retires from the Company at the end of the year.

 

John Morgan, Group Chief Executive Officer said: "I'd like to thank Steve for his exceptional contribution to the Board over the last ten years. Steve has seen the business through a period of significant growth and has helped shape our strategic direction and ensured that the financial stewardship of the business over the last 10 years has supported the Group's long term growth.

 

"I am delighted that Kelly will join the Group in 2024 and I look forward to working with her over the years ahead. She has an excellent track record as a CFO working in a decentralised business, is highly experienced in the construction and property industry and her valuable and significant skills and insight will support me and the Board as the Group continues to develop and grow." 

 

ENDS

A statement concerning particulars of remuneration payments in accordance with section 430(2B) of the Companies Act 2006 will be published in due course.

 

Note to Editors

Morgan Sindall Group

Morgan Sindall Group plc is a leading UK Construction & Regeneration group with annual revenue of £3.6bn, employing around 7,600 employees and operating in the public, regulated and private sectors. It reports through six divisions of Construction, Infrastructure, Fit Out, Property Services, Partnership Housing and Urban Regeneration.

 

Kelly Gangotra

 

Kelly has extensive financial and commercial leadership experience across the construction and property sectors and has served as the CFO of the Healthcare division of Halma plc since August 2022. Prior to Halma, Kelly spent a decade with Skanska Plc in the UK where she was firstly Finance Director from 2012 to 2015 and then CFO and Executive Vice President between 2015 and 2022. She has also held senior finance roles at Alliance Medical and Biffa Waste Services.

 

There are no other details requiring disclosure under Listing Rule 9.6.13 in relation to Kelly Gangotra.

 

 

 

Morgan Sindall Group

Michael Findlay (Chair)

John Morgan

 

Brunswick

Jonathan Glass

Nina Coad

Tel: 020 7307 9200

 

 

 

Tel: 020 7404 5959

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPGAGPUPWGMG
Date   Source Headline
8th Apr 20218:00 amRNSDirectorate Change
1st Apr 202111:59 amRNSTotal Voting Rights
25th Mar 202112:51 pmRNSAnnual Financial Report
12th Mar 20214:37 pmRNSHolding(s) in Company
11th Mar 20214:55 pmRNSDirector/PDMR Shareholding
10th Mar 20213:01 pmRNSDirector/PDMR Shareholding
8th Mar 20214:54 pmRNSDirector/PDMR Shareholding
8th Mar 20214:28 pmRNSDirector/PDMR Shareholding
5th Mar 20213:06 pmRNSDirector/PDMR Shareholding
1st Mar 202111:25 amRNSTotal Voting Rights
25th Feb 20217:00 amRNSFinal Results
17th Feb 20219:06 amRNSHolding(s) in Company
8th Feb 20217:00 amRNSNotice of Results
3rd Feb 20213:42 pmRNSHolding(s) in Company
1st Feb 202110:40 amRNSTotal Voting Rights
22nd Jan 20214:58 pmRNSHolding(s) in Company
4th Jan 202110:56 amRNSTotal Voting Rights
8th Dec 20202:00 pmRNSAdditional Listing
7th Dec 20209:23 amRNSDirector Declaration
3rd Dec 20203:20 pmRNSDirector/PDMR Shareholding
1st Dec 202012:55 pmRNSTotal Voting Rights
4th Nov 20203:00 pmRNSDividend Declaration
4th Nov 20207:00 amRNSTrading Update
2nd Nov 202012:24 pmRNSTotal Voting Rights
20th Oct 20209:57 amRNSBlock listing Interim Review
1st Oct 20201:28 pmRNSTotal Voting Rights
23rd Sep 20205:00 pmRNSHolding(s) in Company
18th Sep 202012:02 pmRNSPrice Monitoring Extension
15th Sep 202010:00 amRNSAdditional Listing
9th Sep 20202:49 pmRNSHolding(s) in Company
2nd Sep 202012:07 pmRNSSecond Price Monitoring Extn
2nd Sep 202012:02 pmRNSPrice Monitoring Extension
1st Sep 20209:11 amRNSTotal Voting Rights
25th Aug 20204:06 pmRNSHolding(s) in Company
21st Aug 20204:15 pmRNSHolding(s) in Company
6th Aug 202012:25 pmRNSHolding(s) in Company
5th Aug 20207:00 amRNSHalf-year Report
3rd Aug 20209:54 amRNSTotal Voting Rights
27th Jul 20207:00 amRNSForward funding secured for £185m New Victoria
14th Jul 20208:30 amRNS£252m forward funding deal of Lewisham Gateway
7th Jul 20203:21 pmRNSHolding(s) in Company
6th Jul 20207:00 amRNSNotice of Results
1st Jul 20202:49 pmRNSHolding(s) in Company
1st Jul 20208:50 amRNSTotal Voting Rights
25th Jun 20203:29 pmRNSHolding(s) in Company
22nd Jun 202011:27 amRNSDirector Declaration
18th Jun 20202:02 pmRNSHolding(s) in Company
10th Jun 202012:02 pmRNSPrice Monitoring Extension
1st Jun 202011:48 amRNSTotal Voting Rights
28th May 20202:52 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.